BCM
BGMS

Bridgeway Capital Management’s Bio Green Med Solution Inc BGMS Stock Holding History

Bridgeway Capital Management’s Portfolio BGMS Stock Details BGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18
Closed -$37.4K – 1382
2023
Q2 		$37.4K Hold
18
– – ﹤0.01% 1347
2023
Q1 		$36.8K Hold
18
– – ﹤0.01% 1336
2022
Q4 		$42.7K Buy
18
+14
+350% +$51.6K ﹤0.01% 1309
2022
Q3 		$19K Buy
+4
New +$20.3K ﹤0.01% 1395

Other funds holding BGMS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KAS
KPP Advisory Services Louisville, Kentucky $791M AUM 28.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Bridgeway Capital Management's BGMS Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Bio Green Med Solution Inc (BGMS) in Q3 2023, closing a stake of 18 shares — an estimated $37.4K sold.

Bridgeway Capital Management first reported a position in BGMS in Q3 2022 and held it in 4 quarters. The position peaked at $42.7K in Q4 2022. 17 funds tracked by Wall St. Rank hold BGMS as of Q3 2023.

  • Bridgeway Capital Management reported no remaining Bio Green Med Solution Inc position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 18 Bio Green Med Solution Inc shares in Q3 2023, an estimated $37.4K.
  • Bridgeway Capital Management first reported a position in Bio Green Med Solution Inc in Q3 2022 and held it in 4 quarters.
  • Bridgeway Capital Management's Bio Green Med Solution Inc position peaked at $42.7K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.